Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Environ Int ; 123: 104-113, 2019 02.
Article in English | MEDLINE | ID: mdl-30503971

ABSTRACT

BACKGROUND: Emerging data suggest that inorganic arsenic exposure and gut microbiome are associated with the risk of cardiovascular disease. The gut microbiome may modify disease risk associated with arsenic exposure. Our aim was to examine the inter-relationships between arsenic exposure, the gut microbiome, and carotid intima-media thickness (IMT)-a surrogate marker for atherosclerosis. METHODS: We recruited 250 participants from the Health Effects of Arsenic Longitudinal Study in Bangladesh, measured IMT and collected fecal samples in year 2015-2016. 16S rRNA gene sequencing was conducted on microbial DNA extracted from the fecal samples. Arsenic exposure was measured using data on arsenic concentration in drinking water wells over time to derive a time-weighted water arsenic index. Multivariable linear regression models were used to test the inter-relationships between arsenic exposure, relative abundance of selected bacterial taxa from phylum to genus levels, and IMT. RESULTS: We identified nominally significant associations between arsenic exposure, measured using either time-weighted water arsenic or urinary arsenic, and the relative abundances of several bacterial taxa from the phylum Tenericutes, Proteobacteria, and Firmicutes. However, none of the associations retained significance after correction for multiple testing. The relative abundances of the family Aeromonadaceae and genus Citrobacter were significantly associated with IMT after correction for multiple testing (P-value = 0.02 and 0.03, respectively). Every 1% increase in the relative abundance of Aeromonadaceae and Citrobacter was related to an 18.2-µm (95% CI: 7.8, 28.5) and 97.3-µm (95% CI: 42.3, 152.3) difference in IMT, respectively. These two taxa were also the only selected family and genus using the LASSO variable selection method. There was a significant interaction between Citrobacter and time-weighted water arsenic in IMT (P for interaction = 0.04). CONCLUSIONS: Our findings suggest a role of Citrobacter in the development of atherosclerosis, especially among individuals with higher levels of arsenic exposure.


Subject(s)
Arsenic/toxicity , Atherosclerosis/etiology , Bacterial Physiological Phenomena , Carotid Intima-Media Thickness , Gastrointestinal Microbiome , Water Pollutants, Chemical/toxicity , Adolescent , Adult , Aged , Arsenic/metabolism , Atherosclerosis/microbiology , Bacteria/classification , Bacteria/genetics , Bangladesh/epidemiology , Biomarkers , Cohort Studies , Environmental Exposure , Female , Humans , Longitudinal Studies , Male , Middle Aged , RNA, Ribosomal, 16S , Risk Factors , Water Pollutants, Chemical/metabolism , Water Wells , Young Adult
2.
Drug Dev Ind Pharm ; 43(6): 947-957, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28122459

ABSTRACT

The purpose of this study was to evaluate the performance of Neusilin® (NEU) a synthetic magnesium aluminometasilicate as an inorganic drug carrier co-processed with the hydrophilic surfactants Labrasol and Labrafil to develop Tranilast (TLT)-based solid dispersions using continuous melt extrusion (HME) processing. Twin-screw extrusion was optimized to develop various TLT/excipient/surfactant formulations followed by continuous capsule filling in the absence of any downstream equipment. Physicochemical characterization showed the existence of TLT in partially crystalline state in the porous network of inorganic NEU for all extruded formulations. Furthermore, in-line NIR studies revealed a possible intermolecular H-bonding formation between the drug and the carrier resulting in the increase of TLT dissolution rates. The capsules containing TLT-extruded solid dispersions showed enhanced dissolution rates and compared with the marketed Rizaben® product.


Subject(s)
Excipients/chemistry , Histamine H1 Antagonists/chemistry , ortho-Aminobenzoates/chemistry , Aluminum Compounds , Capsules , Crystallization , Drug Carriers , Drug Compounding , Histamine H1 Antagonists/administration & dosage , Kinetics , Magnesium Compounds , Particle Size , Silicates , Solubility , Spectroscopy, Near-Infrared , Surface-Active Agents , X-Ray Diffraction , ortho-Aminobenzoates/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...